Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
44
Number of overlapping holdings
22.9%
% of IBB's 212 holdings also in CNCR
61.1%
% of CNCR's 72 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus CNCR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in CNCR |
Overlap | |
|---|---|---|---|---|
 |
BIONTECH SE SPONSORED ADR | 2.5% | 1.5% | 1.5% |
 |
GENMAB A/S SPONSORED ADR | 1.2% | 1.2% | 1.2% |
 |
REGENERON PHARMACEUTICALS | 5.3% | 1.0% | 1.0% |
|
EXELIXIS INC | 1.0% | 2.0% | 1.0% |
|
REVOLUTION MEDICINES, INC. | 0.6% | 1.6% | 0.6% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to CNCR
|
GILEAD SCIENCES INC | 9.9% |
|
VERTEX PHARMACEUTICALS INC | 8.0% |
|
AMGEN INC | 6.9% |
|
REGENERON PHARMACEUTICALS | 4.3% |
|
IQVIA HOLDINGS INC | 3.7% |
|
ALNYLAM PHARMACEUTICALS INC | 3.2% |
 |
ARGENX SE ADR | 3.1% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.7% |
|
ILLUMINA INC | 2.3% |
|
WATERS CORP | 2.3% |
IBB Underweight Relative to CNCR
|
RECURSION PHARMACEUTICALS, INC CLASS | -3.1% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | -2.4% |
|
MONTE ROSA THERAPEUTICS, INC. | -2.1% |
|
REPLIMUNE GROUP, INC. | -1.8% |
|
BRISTOL-MYERS SQUIBB CO | -1.8% |
|
MERSANA THERAPEUTICS, INC. | -1.7% |
|
JANUX THERAPEUTICS, INC. | -1.7% |
|
SCHRODINGER, INC. | -1.7% |
|
XENCOR INC | -1.6% |
|
ZYMEWORKS INC. | -1.6% |